Join Our Respiratory Syncytial Virus (RSV) Oral Medication Study
Runny nose, cough, congestion, wheezing? You might have RSV.
No Cost RSV Testing
If you think you might have RSV, join our clinical research study looking at a potential new (investigational) oral medication treatment for RSV.
About the RSV Oral Medication Study
The Respiratory Syncytial Virus (RSV) Oral Medication Study is researching a potential new (investigational) oral medication to see if it is safe and whether it works to treat respiratory illness caused by respiratory syncytial virus (RSV). RSV can be a serious, life-threatening virus for high-risk adults who are 18 years or older and meet at least 1 of the following criteria:
- Asthma
- Moderate or severe COPD
- Chronic lung disease
- Chronic cardiovascular disease
- ≥60 years of age (vaccinated or nonvaccinated)
RSV is particularly risky for people over 60 years old or those with conditions like COPD, asthma, chronic lung, or heart diseases. That’s why it is important to get quickly tested before symptoms get worse.
While there is no currently approved oral treatment for RSV, we are conducting a trial for a potential treatment option. Our study clinics offer no cost RSV testing for people experiencing symptoms. If you qualify and join the study, you may be able to continue taking your current medications without any interruptions.
You may be able to join the RSV Oral Medication study if you:
- Have 2 or more of the following symptoms:
- Nasal Congestion
- Sore Throat
- Cough
- Wheezing
- Shortness of Breath
- Expectoration / Sputum production
- Are aged 18+ (Aged 60+ must not have been vaccinated unless you have the referenced risk factors)
- Are diagnosed with RSV (Or think your might have RSV)
- Are enrolled within 3 days (72 hours) of your symptoms starting
Receive compensation up to $1,600 for inconvenience and travel.
Why join an RSV clinical trial?
- Access to an investigational oral medication for RSV
- Limited treatment options for high-risk adults
- No FDA-approved oral treatment available
- Don’t have to discontinue current medications to participate
Complete The Questionnaire Below To Apply
Diversity in Clinical Research Studies
People may experience respiratory diseases in different ways. We plan to include people of different races, ethnicities, genders, ages, and backgrounds in the our RSV Oral Medication Study. This will help us to see how the medication being studied works for different people.
Why are clinical studies important?
Clinical trials are the best way to find out if new treatments or vaccines work and how safe they are. If clinical trials show that a new treatment works and is
safe, then it can be approved to be used by the people who need it.
Not all clinical trials test a new treatment or vaccine. “Observational” studies collect information about people’s health during their normal care. This helps researchers learn more about specific health issues.
What is a clinical research study?
A clinical research study is a medical study that helps to answer important questions about an investigational medication or vaccine. such as:
- Is it effective?
- What amount. or dose. may work best?
- How safe is it?
- Are there side effects?
All medications and vaccines must be tested in clinical research studies before they can be approved for use. Without people taking part in these studies, we would have no new medications or vaccines
Clinical research studies should include groups of people who may be at higher risk based on their age, sex. and race/ethnicity.
An Institutional Review Board (IRB)/Ethics Committee (EC), which protects the rights, safety, and wellbeing of the participants has approved this study.
